Office Action Predictor
Application No. 17/917,634

PRE-OPERATIVE SURGICAL PLANNING

Non-Final OA §102§103§112
Filed
Oct 07, 2022
Examiner
ROZANSKI, MICHAEL T
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Cochlear Limited
OA Round
2 (Non-Final)
70%
Grant Probability
Favorable
2-3
OA Rounds
3y 4m
To Grant
99%
With Interview

Examiner Intelligence

70%
Career Allow Rate
623 granted / 895 resolved
Without
With
+39.4%
Interview Lift
avg trend
3y 4m
Avg Prosecution
43 pending
938
Total Applications
career history

Statute-Specific Performance

§101
3.2%
-36.8% vs TC avg
§103
36.8%
-3.2% vs TC avg
§102
23.9%
-16.1% vs TC avg
§112
23.8%
-16.2% vs TC avg
Black line = Tech Center average estimate • Based on career data

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Specification The disclosure is objected to because of the following informalities: In the first paragraph, the priority information should be listed. Appropriate correction is required. Claim Objections Claims 5, 7, 8, 12, and 13 are objected to because of the following informalities: In claims 5, 7, and 8, instances of “the least” should be “the at least”. In claim 12, lines 6 and 7, “of” after “capture” should be deleted. In claim 13, line 5, ‘the’ should be added before ‘recipient’. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 38 and 39 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In claims 38 and 39, “the at least one candidate implanted location” lacks antecedence. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-3, 13-17, and 38-44 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Noble et al (US Pub 2020/0138520 -cited by applicant as WO 2018/200450). Re claims 1, 38, 41-43: Noble discloses a pre-operative surgical planning method, comprising: obtaining anatomical data associated with a head of a recipient of an implantable auditory prosthesis, wherein the implantable auditory prosthesis includes at least one transducer (fig 16; see step 100 of the acquiring of pre-operative CT image of the cochlea, wherein the implant is an electrode which is a type of transducer); determining, based on the anatomical data, one or more suggested implantable placements for the at least one transducer (fig 16; see step 160 of determining a patient-customized plane for electrode placement); displaying, at a display screen, one or more visible indications of the one or more suggested implantable placements (fig 20; see E1-En as displayed indicators of electrode placements); and predict and display on a display, at least based on the anatomical data, visible indications of an estimated outcome for the recipient with the at least one implantable component implanted at the at least one candidate implanted location (0101; see the virtual model showing the suggested placements, wherein the modeling predicts outcomes thereby allowing the trajectory model to be adjusted if necessary). The above steps are executed via non-transitory computer readable storage media with instructions executed by a processor (0164). Re claims 2, 3, 40: The obtaining anatomical data comprises: obtaining medical imaging of the head of the recipient which includes determining the suggested placements includes determining a bone density map of the head from the anatomical data. (fig 14; see the CT scanner to obtain medical images of bone structures as a bone density map). Re claim 13: The method comprises determining, for at least one of the one or more suggested implantable placements, an estimated outcome for the recipient associated with the at least one of the one or more suggested implantable placements; and providing an indication of the estimated outcome for recipient associated with the at least one of the one or more suggested implantable placements (fig 20, 0101; see the virtual model showing the suggested placements, wherein the modeling predicts outcomes thereby allowing the trajectory model to be adjusted if necessary). Re claims 14, 44: Determining the suggested candidate implantable placements for the at least one transducer includes: generating a virtual model of the head of the recipient based on the anatomical data with candidate placements in the reconstruction (fig 20; see the virtual model reconstruction of a portion of the head). Re claim 15: Providing the one or more visible indications comprises: displaying the one or more suggested implantable placements within the virtual model of the head of the recipient (fig 20; see the suggested placements E1-En displayed on the virtual model of a portion of the head). Re claim 16: The method includes receiving one or more user inputs setting an adjusted implantable placement of the at least one transducer; and displaying the adjusted implantable placement of the at least one transducer within the virtual model of the head of the recipient (0206, 0210; see the hardware which includes input for a user to manually edit the implant placements by adjusting the placements). Re claim 17: Providing an indication of an estimated outcome for recipient associated with the adjusted implantable placement (fig 20; 0210; see the editing of the placements which are displayed as visual indications). Re claim 39: The estimated outcome is predicted based on the anatomical data and based on normative data (0092; see the electrode placements based on averaged/normative data). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 4-8 and 10-12 are rejected under 35 U.S.C. 103 as being unpatentable over Noble et al, in view of claim 1, in view of Van den Heuvel (US Pub 2013/0165737 -cited by applicant). Re claims 4-8, 10-12: Noble discloses all features except that the transducer comprises an implantable actuator configured to deliver vibration to the head of the recipient along with which structure the actuator is to be coupled to and the suggested locations and orientations are determined to optimize, for the recipient, sound transmission from the least one implantable actuator to a cochlea of the recipient, while accounting for a bone density of the recipient as a function of voxel; or an implantable sound sensor that optimizes capture of external acoustic sound signals; or an implantable vibration sensor that optimizes an expected sensitivity of the sensor to body noises, wherein the sound sensor and vibration sensor are collocated in a sound input unit that balances an ability of the sensors to capture signals. However, Van den Heuvel implantable actuator configured to deliver vibration to the head of the recipient along with which structure the actuator is to be coupled to and the suggested locations and orientations are determined to optimize, for the recipient, sound transmission from the least one implantable actuator to a cochlea of the recipient, while accounting for a bone density of the recipient as a function of voxel; an implantable sound sensor that optimizes capture of external acoustic sound signals; and an implantable vibration sensor that optimizes an expected sensitivity of the sensor to body noises, wherein the sound sensor and vibration sensor are collocated in a sound input unit that balances an ability of the sensors to capture signals (0026, 0030; see the implantable actuator and the microphones for detecting sound deliver vibrations to the head and optimize sound transmission along with the capture of external acoustic sound signals; both components together form a sound input unit). It would have been obvious to the skilled artisan to modify Noble, to incorporate the actuator and sound sensor as taught by Van de Heuvel, in order to improve surgical planning for middle ear implants. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL T ROZANSKI whose telephone number is (571)272-1648. The examiner can normally be reached Mon - Fri 8:00-4:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Christopher Koharski can be reached at 571-272-7230. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL T ROZANSKI/Primary Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Oct 07, 2022
Application Filed
Dec 02, 2025
Non-Final Rejection — §102, §103, §112
Mar 30, 2026
Response Filed
Apr 08, 2026
Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology. Study what changed to get past this examiner.

Patent 12564331
SENSOR LOCALIZATION IN A MAGNETOENCEPHALOGRAPHY (MEG) SYSTEM
2y 5m to grant Granted Mar 03, 2026
Patent 12558059
BODY CAVITY INSERTION-TYPE ULTRASOUND PROBE AND METHOD OF MANUFACTURING ACOUSTIC MATCHING LAYER
2y 5m to grant Granted Feb 24, 2026
Patent 12551295
CAMERA TRACKING SYSTEM IDENTIFYING PHANTOM MARKERS DURING COMPUTER ASSISTED SURGERY NAVIGATION
2y 5m to grant Granted Feb 17, 2026
Patent 12533177
METHODS AND SYSTEMS FOR REAL-TIME PLANNING AND MONITORING OF ABLATION NEEDLE DEPLOYMENT IN TISSUE
2y 5m to grant Granted Jan 27, 2026
Patent 12533111
SPREAD SPECTRUM CODED WAVEFORMS IN ULTRASOUND DIAGNOSTICS
2y 5m to grant Granted Jan 27, 2026

AI Strategy Recommendation

Click below to generate an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

2-3
Expected OA Rounds
70%
Grant Probability
99%
With Interview (+39.4%)
3y 4m
Median Time to Grant
Moderate
PTA Risk
Based on 895 resolved cases by this examiner